Schedule 13G ownership disclosure

JUPITER NEUROSCIENCES INC

Common Stock, par value $0.0001 per share · CUSIP: 48208B203

Event date: 2026-09-30

Filing-level shares
132,867
Percent of class
10.1%
  • PharmAla Biotech Holdings Inc.

    Shares: 132,867 · Class: 10.1%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000912282-26-001403
Form type
SCHEDULE 13G/A
Filer
PharmAla Biotech Holdings Inc.
CIK
CIK 2155983
Filed
Oct 26, 2026
Reporting period
Sep 30, 2026
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub